Expression profiling studies have confirmed that MIR17HG is ubiquitously overexpressed in diverse tumour types, including both haematopoietic malignancies and solid tumours, such as those derived from stomach, prostate and lung tissue29. Here, MIR17HG is linked to neoplasm.